We found that hypermutation-associated TP53~MLH1 and NOTCH1~TET2 sequential mutations affected the survival of patients with colorectal cancer (p-values = 0.027 and 0.0001, respectively, Figure 7A,B). Here, TP53 is linked to colorectal cancer.